FP179BASELINE CHARACTERISTICS IN THE "CARDINAL" TRIAL: A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME. (13th June 2019) - Knebelmann, Bertrand; Appel, Gerald; Block, Geoffrey; Chin, Melanie; Goldsberry, Angie; Inker, Lesley; Kashtan, Clifford; Meyer, Colin; Nozu, Kandai; Pergola, Pablo; Rastogi, Anjay; Rheault, Michelle; et al.